Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Al | INSM Message Board Posts

Insmed Incorporated

  INSM website


  • Get 3 months of ad-free premium service for every $25 you contribute
    to support critical site improvement efforts.
    With no recurring subscription
    to worry about, this an ideal way to test drive our premium service.

    Premium features, such as multi-message viewing (i.e., being able to open
    up to 100 messages with a single click) can save you lots of time
    over the course of a busy day, to say nothing of an entire year!
    Watch this 2-min video to see why premium is right for you.


    *Offer expires at midnight

INSM   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  46236 of 48234  at  6/13/2019 8:37:54 AM  by

bohemian


 In response to msg 46233 by  b_leaguered
view thread

Re: Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP)

SVRA might be a good buy under three. They missed the primary endpoint, but hit the secondary. Reminds me of another stock that Iíve followed for years.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 164
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
46237 Re: Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) JAD9000 0 6/13/2019 8:41:52 AM
46238 Re: Savara Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) zake1 0 6/13/2019 8:46:43 AM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...